SCHEMBL19207740

SCHEMBL19207740

CN1C(=O)C(NC(=O)c2nn(Cc3cnn(C)c3)cc2F)COc2cccnc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207736 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19207542 0.91 RIPK1 (1.00) RIPK1
SCHEMBL19207543 0.91 RIPK1 (1.00) RIPK1
SCHEMBL19207781 0.91 RIPK1 (1.00) RIPK1
SCHEMBL19207777 0.91 RIPK1 (1.00) RIPK1
SCHEMBL19224722 0.90 RIPK1 (0.91) RIPK1
SCHEMBL19207767 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207762 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207811 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207809 0.88 RIPK1 (1.00) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed